Clinivation's Global Market Clearance services leverage our excellence in market clearance and many years of focused, successful experience in developing and supporting thousands of medtech market clearance applications in all of the major and emerging world markets. Our many years of successful experience spans from comprehensive initiation, support, and execution of the most complex Class III PMA programs to focused global market clearance initiatives.

Olympus and Gyrus ACMI, two of the world's leading suppliers of medical visualization and energy systems, have joined forces to create a more versatile organization to push beyond the boundaries of minimally invasive surgery. The Gyrus ACMI brand of 'See' and 'Treat' products features a comprehensive portfolio of instruments designed to improve visualization and provide fast, accurate tissue management that is less traumatic to the patient. Gyrus ACMI has three proprietary divisions: a Urology & Gynecology Division for Endoscopic and Diagnostic Solutions for Urologists and Gynecologists, a Surgical Division for less invasive laparoscopic and open solutions for surgeons, and a ENT Division for complete ENT surgical solutions.

In addition, in areas where Gyrus ACMI have no direct market presence they have brought their technology to the market through out-license and manufacturing relationships with third parties.

Gyrus ACMI operates primarily out of the United States, where each division has a significant salesforce and the majority of manufacturing is carried out. The company has a direct presence in countries around the world and work through a global network of distribution partners. The Group employs approximately 1600 staff worldwide

For more information, please visit www.gyrusacmi.com.

Clinivation is the leading provider of integrated solutions that enable global market clearance. Guided by our singular vision - "Excellence in Market Clearance" - clinivation accelerates the entire market clearance cycle to advance new worldwide revenue and achieve new milestones of enterprise value.

Used in over 1,000,000 product registrations by more than 100 companies worldwide, clinivation's end-to-end technology and services deliver on our vision by eliminating revenue traps from global market clearance operations, increasing process velocity with on-demand regulatory intelligence, automating clearance-driven business controls, simplifying content unification into market clearance applications, aligning quality systems with global market clearance priorities, streamlining clinical development with clearance-focused trials, and enabling management with key performance indicators for continuous improvement and effective governance.

The world's leading medical device, diagnostics, hospital supply, and dental supply companies select clinivation because of our medtech industry focus and our unique, integrated solutions that seamlessly adapt to existing business processes and enterprise infrastructure- without the need to write custom code.

Our core brands include the clinivation Global^® xi market clearance platform, clinivation WorldView^® on-demand regulatory intelligence, and clinivation Clinical Suite^® and clinivation Registry Suite^® electronic data capture and clinical data management software.

Founded in 1999, the company is headquartered in Natick, Massachusetts, with regional offices in North America and Asia.

Visit clinivation online at www.clinivation.com

For more information on clinivation's integrated solutions that enable global market clearance, please click here or call us at 508.655.6560.